ICU Medical Inc. (ICUI) Drops 8.49% on February 04

Equities Staff |

ICU Medical Inc. (ICUI) was one of the Russell 2000's biggest losers for Thursday February 04 as the stock slid 8.49% to $89.28, a loss of $-8.2867 per share. Starting at an opening price of $105.00 a share, the stock traded between $85.99 and $105.00 over the course of the trading day. Volume was 574,828 shares over 6,144 trades, against an average daily volume of 151,434 shares and a total float of 15.98 million.

The losses send ICU Medical Inc. down to a market cap of $1.43 billion. In the last year, ICU Medical Inc. has traded between $124.69 and $82.71, and its 50-day SMA is currently $106.39 and 200-day SMA is $103.98.

The stock has a P/E Ratio of 33.6.

ICU Medical Inc is engaged in the development, manufacture and sale of medical devices used in infusion therapy, oncology and critical care applications. Its products include needlefree connectors, nanoclave, chemoclock, chemoclave, and among others.

ICU Medical Inc. is based out of San Clemente, CA and has some 2,280 employees. Its CEO is Vivek Jain.

For a complete fundamental analysis analysis of ICU Medical Inc., check out’s Stock Valuation Analysis report for ICUI. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Relevium Technologies Inc.

Relevium Technologies Inc is engaged in the acquisition of products, technologies and businesses relating to musculoskeletal function, specifically Pain Relief, Injury Recovery and Active Performance.

Private Markets

Almond Smart Home Router by Securifi

Securifi sells user friendly touch screen routers that also have support for IoT/home automation.Securifi’s Almond revolutionized wireless router setup with its easy to use Touchscreen Interface in 2012. Now our…


D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…